文献速递中医内科中药与中成药合理使用

银马解毒颗粒通过抑制炎症减轻LPS诱导的大鼠急性肺损伤

Yinma Jiedu Granule attenuates LPS-induced acute lung injury in rats via suppressing inflammation level.
PubMed 文献 · J Ethnopharmacol · 2023-03-15

本研究探讨银马解毒颗粒(YMJD)对脂多糖(LPS)诱导的大鼠急性肺损伤(ALI)的保护作用及机制。大鼠连续14天灌胃YMJD后气管滴注LPS造模,结果显示YMJD改善一般状态、减轻体重下降和血清乳酸水平、减轻肺水肿和病理损伤,并降低支气管肺泡灌洗液中白细胞等浸润及肺组织TNF-α、IL-1β浓度,抑制iNOS和COX-2表达,升高SOD活性、降低MDA水平;RNA测序和Western blot证实YMJD抑制JAK2/STAT1通路活化。

要点

  • YMJD可减轻LPS诱导的大鼠急性肺损伤和肺部炎症。
  • YMJD降低肺组织氧化应激并抑制JAK2/STAT1通路活化。
  • 为YMJD临床用于ALI等炎症性肺病提供实验依据。

核心结论

  • 银马解毒颗粒通过抑制炎症和氧化应激减轻LPS诱导的大鼠急性肺损伤,机制与抑制JAK2/STAT1活化相关。

研究设计与样本

  • 大鼠连续14天给予YMJD或溶剂对照,末次给药2小时后气管滴注LPS诱导ALI模型,采用HPLC进行指纹图谱分析并研究疗效与分子机制。

主要发现

  • YMJD改善大鼠一般状态、减少体重下降和血清乳酸(LA)水平,减轻肺水肿和肺组织病理损伤。
  • YMJD降低支气管肺泡灌洗液(BALF)中白细胞(WBC)、淋巴细胞(LYM)、单核细胞(MON)和中性粒细胞(NEUT)浸润。
  • YMJD降低肺组织TNF-α和IL-1β浓度,抑制iNOS和COX-2表达。
  • YMJD升高肺组织SOD活性并降低MDA水平。
  • RNA测序识别JAK2/STAT1为重要通路,Western blot验证YMJD抑制JAK2/STAT1通路活化。

临床怎么用

  • 本研究为动物实验,结果提示YMJD可能用于ALI等炎症性肺病的治疗,但临床使用需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Yinma Jiedu Granule (YMJD) is a traditional Chinese patent medicine (CPM), which has been proved to have anti-inflammatory effects and therapeutical effects on obstructive pulmonary disease. AIM OF STUDY: The purpose of the current investigation is to find out if YMJD can alleviate acute lung injury (ALI) induced by lipopolysaccharide (LPS) in rats and its underlying mechanisms. MATERIALS AND METHODS: Rats were treated with either vehicle or YMJD for 14 consecutive days, and 2 h after the last administration, the rat model of ALI was induced by the intratracheal instillation of LPS. High performance liquid chromatography (HPLC) was applied for the fingerprint analysis of YMJD. The efficacy and molecular mechanisms were investigated. RESULTS: The results showed that treatment with YMJD improved the general state of rats, reduced weight loss and serum lactate (LA) levels, attenuated pulmonary edema and pathological damage of the lung tissue. Moreover, we found that YMJD effectively decreased the infiltration of white blood cells (WBC), lymphocytes (LYM), mononuclear cells (MON) and neutrophils (NEUT) in bronchoalveolar lavage fluid (BALF), reduced the concentration of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) and inhibited inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression in the lung tissue. Additionally, we found that YMJD could significantly increase the activity of superoxide dismutase (SOD) and reduce the malondialdehyde (MDA) level in the lung tissue. By employing RNA-sequencing, we have identified that JAK2/STAT1 is an important pathway that is involved in the lung protection of YMJD, and further Western blot assay verified that YMJD could effectively inhibit the activation of the JAK2/STAT1 pathway. CONCLUSIONS: YMJD could attenuate LPS-induced ALI through suppressing inflammation and oxidative stress in the lung tissue of rats, associating with the inhibition of JAK2/STAT1 activation. These findings provide evidence for the clinical use of YMJD for treatment of inflammatory pulmonary diseases like ALI.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Li G, Ma J, Yang Y, et al. Yinma Jiedu Granule attenuates LPS-induced acute lung injury in rats via suppressing inflammation level. J Ethnopharmacol. 2023. PMID: 36931412. doi:10.1016/j.jep.2023.116292

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。